Ocular Manifestations of ANCA-associated Vasculitis

https://doi.org/10.1016/j.rdc.2010.05.005Get rights and content

Section snippets

Conjunctival, episcleral, and scleral disease

These manifestations can sometimes be difficult to distinguish from each other because they all can present with ocular redness and discomfort. The key to distinguishing them is recognizing the depth of tissue involvement associated with the blood vessel plexus (Fig. 1). For example, in episcleritis, the superficial episcleral plexus is thought to be affected by the vasculitis process (see Fig. 1B), in contrast to scleritis, in which the deep episcleral plexus is affected (see Fig. 1C).

Corneal manifestations

Corneal findings of the ANCA-associated vasculitides are often present in concert with other anterior segment manifestations, particularly necrotizing scleritis.12 Conjunctival scarring with resultant tear deficiency, entropion, trichiasis, and poor eyelid closure can produce an exposure keratopathy, secondary infectious ulceration, and even corneal perforation. Proptosis from orbital disease (as discussed later) can also cause exposure and its sequelae.

In addition to these secondary corneal

Retinovascular

Posterior segment complications are uncommon, but the blood vessels of the retinal and choroidal circulation of the eye can be affected by ANCA-associated vasculitic disease. These patients tend to present with a decline in visual acuity or loss of visual field, because vascular occlusion leads to rapid retinal ischemia and death of retinal photoreceptors (Fig. 6). Several cases of branch or central retinal vein occlusion (RVO) have been reported in patients with WG.40, 41, 42 The arterial

Orbital

Orbital involvement is one of the most common manifestations of WG, occurring in almost half of the patients with WG and ophthalmic disease.5, 48 In a review of 29 patients with orbital and adnexal WG, signs and symptoms included proptosis in 69% of patients; sinusitis in 69%; epiphora (overflow of tears from obstruction of lacrimal duct) in 52%; diplopia in 52%; eyelid edema and erythema in 31%; orbital pain in 24%; and decreased visual acuity with evidence of optic nerve compression in 17%.49

Other manifestations

Anterior, intermediate, and posterior uveitis can also be seen in ANCA-associated disease but are uncommon. They have been reported to occur in 0% to 10% of patients with WG.5, 6, 7 Iridocyclitis with an anterior chamber inflammatory reaction typically occurs secondary to keratitis or scleritis rather than as a primary manifestation.21 Granulomatous anterior uveitis with large inflammatory deposits on the posterior corneal surface has been seen in patients with WG.6, 63 One report described a

Summary

The ANCA-associated vasculitides can affect virtually any ocular or adnexal structure. WG commonly involves the eye, whereas ophthalmic findings in CSS and particularly MPA are much rarer. These diseases can have significant visual morbidity, with some of the manifestations causing pain and blindness. More importantly, because these diseases can be fatal, physicians must recognize ocular symptoms and findings on examination as being indicators of a serious underlying systemic disease, so that

First page preview

First page preview
Click to open first page preview

References (80)

  • A. Hara et al.

    Microscopic polyangiitis with ocular manifestations as the initial presenting sign

    Am J Med Sci

    (2007)
  • A. Galor et al.

    Scleritis and peripheral ulcerative keratitis

    Rheum Dis Clin North Am

    (2007)
  • R.S. Feder et al.

    Conjunctival resection for the treatment of the rheumatoid corneal ulceration

    Ophthalmology

    (1984)
  • M.H. Greenberger

    Central retinal artery closure in Wegener's granulomatosis

    Am J Ophthalmol

    (1967)
  • T. Iida et al.

    Retinal and choroidal arterial occlusion in Wegener's granulomatosis

    Am J Ophthalmol

    (2002)
  • S.R. Perry et al.

    The clinical and pathologic constellation of Wegener granulomatosis of the orbit

    Ophthalmology

    (1997)
  • T.L. Woo et al.

    Australasian orbital and adnexal Wegener's granulomatosis

    Ophthalmology

    (2001)
  • T. Takanashi et al.

    Orbital inflammatory pseudotumor and ischemic vasculitis in Churg-Strauss syndrome: report of two cases and review of the literature

    Ophthalmology

    (2001)
  • P.H. Kalina et al.

    Diagnostic value and limitations of orbital biopsy in Wegener's granulomatosis

    Ophthalmology

    (1992)
  • P.W. Hardwig et al.

    Surgical management of nasolacrimal duct obstruction in patients with Wegener's granulomatosis

    Ophthalmology

    (1992)
  • B.J. Rosenblatt et al.

    Asymptomatic optic neuropathy associated with Churg-Strauss syndrome

    Ophthalmology

    (2003)
  • C.O. Savage et al.

    New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis

    Curr Opin Rheumatol

    (2002)
  • B.H. Ewert et al.

    Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells

    Kidney Int

    (1992)
  • G.S. Hoffman et al.

    Wegener granulomatosis: an analysis of 158 patients

    Ann Intern Med

    (1992)
  • L. Guillevin et al.

    Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients

    Arthritis Rheum

    (1999)
  • A.S. Fauci et al.

    Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years

    Ann Intern Med

    (1983)
  • J.C. Caster et al.

    Microscopic polyangiitis with ocular involvement

    Arch Ophthalmol

    (1996)
  • R. Margolis et al.

    Conjunctival involvement in Churg-Strauss syndrome

    Ocul Immunol Inflamm

    (2007)
  • F. Nissim et al.

    A limited form of Churg-Strauss syndrome: ocular and cutaneous manifestations

    Arch Pathol Lab Med

    (1982)
  • P.G. Watson et al.

    Scleritis and episcleritis

    Br J Ophthalmol

    (1976)
  • M. Sainz de la Maza et al.

    Severity of scleritis and episcleritis

    Ophthalmology

    (1994)
  • J.E. Thorne et al.

    Ocular manifestations of vasculitis

    Rheum Dis Clin North Am

    (2001)
  • P.G. Watson et al.

    Episcleritis and scleritis

    Br J Ophthalmol

    (1976)
  • M. Sainz de la Maza et al.

    Scleritis associated with systemic vasculitis diseases

    Ophthalmology

    (1995)
  • S.L. Harper et al.

    Wegener's granulomatosis: the relationship between ocular and systemic disease

    J Rheumatol

    (2001)
  • C.S. Foster et al.

    Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression

    Ophthalmology

    (1984)
  • M. Mihara et al.

    Ocular manifestations in patients with microscopic polyangiitis

    Eur J Ophthalmol

    (2005)
  • M. Sainz de la Maza et al.

    Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy

    Arch Ophthalmol

    (2002)
  • J.B. Ladas et al.

    Systemic disorders associated with peripheral corneal ulceration

    Curr Opin Ophthalmol

    (2000)
  • J.K. Darlington et al.

    Peripheral nonulcerative keratitis as a presenting sign of microscopic polyangiitis

    Cornea

    (2001)
  • Cited by (49)

    • Vascular abnormalities in uveitis

      2021, Survey of Ophthalmology
      Citation Excerpt :

      Ocular inflammatory conditions such as BD, presumed ocular tuberculosis, SLE and sarcoidosis can be associated with branch retinal vein occlusions.24,55 Central retinal vein occlusion and central retinal artery occlusion are other rare manifestations of occlusive vasculitis associated with systemic inflammatory disorders such as SLE, giant cell arthritis, PAN, granulomatosis with polyangiitis, and ARN.7,19,42 Unilateral or bilateral branch retinal vein occlusions, branch retinal artery occlusion, central retinal vein occlusion, central retinal artery occlusion, and cilioretinal artery occlusion can happen in antiphospholipid antibody syndrome.84

    • Ocular involvement in granulomatosis with polyangiitis: A single-center cohort study on 63 patients

      2019, Autoimmunity Reviews
      Citation Excerpt :

      As observed in our cohort, ocular disease may evolve in parallel or isolated from other GPA manifestations. Scleritis was the most commonly recurrent ocular manifestation, in up to 30% of the cases, relapsing in association with other systemic manifestations in two thirds of the cases, confirming that scleritis could be a surrogate marker of disease activity [9]. On the other hand, orbital disease and optic nerve involvement relapses were more commonly independent from other systemic manifestations.

    • Granulomatosis with polyangiitis confined to lacrimal gland, a case report

      2017, Archivos de la Sociedad Espanola de Oftalmologia
    View all citing articles on Scopus
    View full text